Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Margin (2016 - 2025)

Utah Medical Products has reported FCF Margin over the past 16 years, most recently at 37.24% for Q4 2025.

  • Quarterly results put FCF Margin at 37.24% for Q4 2025, up 526.0% from a year ago — trailing twelve months through Dec 2025 was 37.18% (up 148.0% YoY), and the annual figure for FY2025 was 37.18%, up 148.0%.
  • FCF Margin for Q4 2025 was 37.24% at Utah Medical Products, down from 39.25% in the prior quarter.
  • Over the last five years, FCF Margin for UTMD hit a ceiling of 54.89% in Q1 2023 and a floor of 25.5% in Q2 2024.
  • Median FCF Margin over the past 5 years was 39.14% (2022), compared with a mean of 39.41%.
  • Biggest five-year swings in FCF Margin: tumbled -1135bps in 2022 and later skyrocketed 1586bps in 2023.
  • Utah Medical Products' FCF Margin stood at 36.66% in 2021, then increased by 13bps to 41.56% in 2022, then grew by 2bps to 42.5% in 2023, then decreased by -25bps to 31.98% in 2024, then rose by 16bps to 37.24% in 2025.
  • The last three reported values for FCF Margin were 37.24% (Q4 2025), 39.25% (Q3 2025), and 28.35% (Q2 2025) per Business Quant data.